These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 28890154

  • 1. Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma.
    Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Sahani DV, Pergolini I, Negreros-Osuna AA, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.
    Pancreatology; 2017; 17(6):920-926. PubMed ID: 28890154
    [Abstract] [Full Text] [Related]

  • 2. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H.
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [Abstract] [Full Text] [Related]

  • 3. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.
    Yamada S, Fujii T, Shimoyama Y, Kanda M, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Nakao A, Kodera Y.
    Ann Surg Oncol; 2014 Jul; 21(7):2444-52. PubMed ID: 24562937
    [Abstract] [Full Text] [Related]

  • 4. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L, Siddiqui AA, Laique SN, Saumoy M, Kahaleh M, Yoo J, Kalra A, Mathew A, Sterling J, Rao R, Lieberman M, Cosgrove N, Sharaiha RZ.
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [Abstract] [Full Text] [Related]

  • 5. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.
    Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS.
    Cancer; 2002 Jan 01; 94(1):62-77. PubMed ID: 11815961
    [Abstract] [Full Text] [Related]

  • 6. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Hirono S, Kawai M, Okada KI, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Yanagisawa A, Yamaue H.
    JAMA Surg; 2017 Mar 15; 152(3):e165054. PubMed ID: 28122068
    [Abstract] [Full Text] [Related]

  • 7. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.
    Mino-Kenudson M, Fernández-del Castillo C, Baba Y, Valsangkar NP, Liss AS, Hsu M, Correa-Gallego C, Ingkakul T, Perez Johnston R, Turner BG, Androutsopoulos V, Deshpande V, McGrath D, Sahani DV, Brugge WR, Ogino S, Pitman MB, Warshaw AL, Thayer SP.
    Gut; 2011 Dec 15; 60(12):1712-20. PubMed ID: 21508421
    [Abstract] [Full Text] [Related]

  • 8. Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm.
    Sclabas GM, Barton JG, Smyrk TC, Barrett DA, Khan S, Kendrick ML, Reid-Lombardo KM, Donohue JH, Nagorney DM, Que FG.
    J Am Coll Surg; 2012 Jan 15; 214(1):27-32. PubMed ID: 22112419
    [Abstract] [Full Text] [Related]

  • 9. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma.
    Yopp AC, Katabi N, Janakos M, Klimstra DS, D'Angelica MI, DeMatteo RP, Fong Y, Brennan MF, Jarnagin WR, Allen PJ.
    Ann Surg; 2011 May 15; 253(5):968-74. PubMed ID: 21422912
    [Abstract] [Full Text] [Related]

  • 10. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.
    Cancer; 2006 Jun 25; 108(3):163-73. PubMed ID: 16550572
    [Abstract] [Full Text] [Related]

  • 11. Intraductal papillary mucinous neoplasm.
    Shi C, Hruban RH.
    Hum Pathol; 2012 Jan 25; 43(1):1-16. PubMed ID: 21777948
    [Abstract] [Full Text] [Related]

  • 12. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
    Tan MC, Basturk O, Brannon AR, Bhanot U, Scott SN, Bouvier N, LaFemina J, Jarnagin WR, Berger MF, Klimstra D, Allen PJ.
    J Am Coll Surg; 2015 May 25; 220(5):845-854.e1. PubMed ID: 25840541
    [Abstract] [Full Text] [Related]

  • 13. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N, Ohtsuka T, Kono H, Fujiwara K, Oda Y, Aishima S, Ito T, Ishigami K, Tokunaga S, Ohuchida K, Takahata S, Nakamura M, Mizumoto K, Tanaka M.
    Ann Surg; 2013 Jul 25; 258(1):141-51. PubMed ID: 23532108
    [Abstract] [Full Text] [Related]

  • 14. Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm.
    Miyasaka Y, Ohtsuka T, Tamura K, Mori Y, Shindo K, Yamada D, Takahata S, Ishigami K, Ito T, Tokunaga S, Oda Y, Mizumoto K, Nakamura M, Tanaka M.
    Ann Surg; 2016 Jun 25; 263(6):1180-7. PubMed ID: 26334637
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S, Schirren M, Klauss M, Bergmann F, Hackert T, Hartwig W, Strobel O, Grenacher L, Büchler MW, Werner J.
    Surgery; 2012 Sep 25; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of clinical meaning of histological subtypes of intraductal papillary mucinous neoplasm of the pancreas.
    Kang MJ, Lee KB, Jang JY, Han IW, Kim SW.
    Pancreas; 2013 Aug 25; 42(6):959-66. PubMed ID: 23462330
    [Abstract] [Full Text] [Related]

  • 17. Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.
    Correa-Gallego C, Do R, Lafemina J, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ.
    Ann Surg Oncol; 2013 Dec 25; 20(13):4348-55. PubMed ID: 24046103
    [Abstract] [Full Text] [Related]

  • 18. Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain.
    Hara T, Ikebe D, Odaka A, Sudo K, Nakamura K, Yamamoto H, Itami M, Hirata T, Kashimura J, Yamaguchi T.
    Ann Surg; 2013 Jun 25; 257(6):1103-11. PubMed ID: 23364699
    [Abstract] [Full Text] [Related]

  • 19. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
    Watanabe Y, Endo S, Nishihara K, Ueda K, Mine M, Tamiya S, Nakano T, Tanaka M.
    Surg Today; 2018 Nov 25; 48(11):1011-1019. PubMed ID: 29961172
    [Abstract] [Full Text] [Related]

  • 20. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.
    J Am Coll Surg; 2015 May 25; 220(5):839-44. PubMed ID: 25840549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.